Skip to content

Randomised trial, 2009

Does duloxetine help treat premenstrual dysphoric disorder?

Yes. 65% of the 20 women improved by at least 50%, with statistically significant overall symptom reduction. However, this was a small uncontrolled pilot study, so larger research is needed to confirm results.

Early or limited evidence 20 women with premenstrual dysphoric disorder

What they did

20 women with PMDD took 60 mg of duloxetine daily for three menstrual cycles. Before treatment started, they had two confirmation cycles including one on placebo. Doctors measured their symptoms before and after.

What they found

65% of women had at least a 50% reduction in symptoms. Symptom scores dropped significantly in the first cycle and stayed improved throughout (p=0.0002). Functional impairment and quality of life also improved. Common side effects were dry mouth, nausea, drowsiness, insomnia, decreased appetite, decreased libido, and sweating.

What it means for you

Duloxetine may help PMDD symptoms, and side effects were generally mild with benefits lasting throughout treatment. However, this was a small uncontrolled pilot study. Larger double-blind placebo-controlled studies are needed.

65%

Women with at least 50% symptom reduction

20

Number of women

3

Menstrual cycles of treatment

About the study

Original title
Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial
Authors
Ramos MG, Hara C, Rocha FL
Journal
The international journal of neuropsychopharmacology
Year
2009
Study design
Randomised trial
Participants
20
What was tested
Duloxetine 60 mg daily for three menstrual cycles

Topics